Literature DB >> 21463965

Effect of intravenous amantadine on dopaminergic-drug-resistant freezing of gait.

Young Eun Kim, Ji Young Yun, Beom S Jeon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21463965     DOI： 10.1016/j.parkreldis.2011.03.010

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN： 1353-8020            Impact factor:   4.891


× No keyword cloud information.
  10 in total

1.  Intravenous amantadine on freezing of gait in Parkinson's disease: a randomized controlled trial.

Authors:  Jee Young Lee; Sohee Oh; Jong Min Kim; Ji Sun Kim; Eungseok Oh; Hee-Tae Kim; Beom S Jeon; Jin Whan Cho
Journal:  J Neurol       Date:  2013-09-22       Impact factor: 4.849

2.  Amantadine for freezing of gait in patients with Parkinson disease.

Authors:  Roneil Malkani; Cindy Zadikoff; Onur Melen; Aleksandar Videnovic; Emily Borushko; Tanya Simuni
Journal:  Clin Neuropharmacol       Date:  2012 Nov-Dec       Impact factor: 1.592

3.  Preliminary study of intravenous amantadine treatment for ataxia management in patients with probable multiple system atrophy with predominant cerebellar ataxia.

Authors:  Jinyoung Youn; Hyeeun Shin; Ji Sun Kim; Jin Whan Cho
Journal:  J Mov Disord       Date:  2012-05-30

4.  Amantadine induced corneal edema in a patient with primary progressive freezing of gait.

Authors:  Young Eun Kim; Ji Young Yun; Hui-Jun Yang; Han-Joon Kim; Mee Kum Kim; Won Ryang Wee; Beom S Jeon
Journal:  J Mov Disord       Date:  2013-10-30

Review 5.  Freezing of gait in Parkinson's disease: pathophysiology, risk factors and treatments.

Authors:  Chao Gao; Jun Liu; Yuyan Tan; Shengdi Chen
Journal:  Transl Neurodegener       Date:  2020-04-15       Impact factor: 8.014

6.  Effect of Repeated Intravenous Amantadine Infusions in Patients with Parkinson's Disease: An Open-Label Pilot Study.

Authors:  Alexander Khlebtovsky; Israel Steiner; Therese Treves; Ruth Djaldetti
Journal:  Clin Transl Sci       Date:  2019-09-24       Impact factor: 4.689

Review 7.  Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches.

Authors:  Pedro Cruz-Vicente; Luís A Passarinha; Samuel Silvestre; Eugenia Gallardo
Journal:  Molecules       Date:  2021-04-11       Impact factor: 4.411

8.  Associations Between Amantadine Usage, Gait, and Cognition in PSP: A post-hoc Analysis of the Davunetide Trial.

Authors:  Marian L Dale; Barbara H Brumbach; Adam L Boxer; Amie L Hiller
Journal:  Front Neurol       Date:  2020-12-21       Impact factor: 4.003

9.  Intravenous amantadine for freezing of gait resistant to dopaminergic therapy: a randomized, double-blind, placebo-controlled, cross-over clinical trial.

Authors:  Young Eun Kim; Ji Young Yun; Hui June Yang; Han-Joon Kim; Namyi Gu; Seo Hyun Yoon; Joo-Youn Cho; Beom S Jeon
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

Review 10.  Freezing of Gait in Parkinsonism and its Potential Drug Treatment.

Authors:  Li-Li Zhang; S Duff Canning; Xiao-Ping Wang
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.